Keyword: NYU Langone Medical Center
A drug that blocks heat shock protein 90 (HSP90) offer a new way of treating an aggressive form of leukemia.
The thoracic oncologist will head up a team tasked with overseeing the advance of Lilly’s portfolio of immuno-oncology prospects.
Two separate studies are unlocking the structure and function of Klotho proteins and shedding new light on their role in age-related disorders.
Two commonly mutated genes in lung cancer may make some tumor cells especially vulnerable to an experimental drug from Calithera Biosciences.
A new finding by scientists at NYU may prompt fresh ideas for reversing the buildup of plaque in arteries.
Scientists at NYU Langone reported data showing that deep brain stimulation improved symptoms for patients with Tourette syndrome.
New York University researchers seeking to prove how a protein protects asthmatics from lung damage may have found a new treatment for Gaucher disease, in which fat accumulates in cells and certain organs.
Vedanta Biosciences has partnered with the NYU Langone Medical Center to develop microbiome-derived immunotherapies specifically for use paired with checkpoint inhibitors.
Investigators at NYU Langone Medical Center and the University of Colorado at Boulder have identified a gene in mice that triggers the repair of injured muscle by adult stem cells.